Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 18, 2021 at 02:22 pm EDT
Guided Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 561,000 compared to USD 369,000 a year ago. Net loss was USD 1.034 million compared to USD 6.749 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.57 a year ago. For the half year, operating loss was USD 1.440 million compared to USD 610,000 a year ago. Net loss was USD 1.694 million compared to USD 4.020 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 0.48 a year ago.